Cargando…

Combination Chemohormonal Therapy in Metastatic Salivary Duct Carcinoma

Patient: Male, 68-year-old Final Diagnosis: Salivary duct carcinoma Symptoms: Bone pain • dyspnea Medication:— Clinical Procedure: Chemotherapy Specialty: Oncology OBJECTIVE: Rare disease BACKGROUND: Salivary duct carcinoma (SDC) is a rare, aggressive head and neck cancer with frequent metastases. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Il Seok Daniel, Moyers, Justin, Thung, Irene, Thinn, Mie Mie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347037/ https://www.ncbi.nlm.nih.gov/pubmed/32601266 http://dx.doi.org/10.12659/AJCR.925181

Ejemplares similares

Activated Prothrombin Complex Concentrate-Induced Atypical Hemolytic Uremic Syndrome Treated with Eculizumab
por: Tsai, Hsin Hsiang Clarence, et al.
Publicado: (2021)

Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
por: Babst, Christa, et al.
Publicado: (2022)

Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer
por: Aguiar, Pedro Nazareth, et al.
Publicado: (2017)

Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report
por: Thinn, Mie Mie, et al.
Publicado: (2019)

Clinical efficacy of neoadjuvant chemohormonal therapy combined with laparoscopic radical prostatectomy in high-risk Prostate Cancer
por: Zhang, Peng, et al.
Publicado: (2022)

Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma
por: Pan, Jen-Jung, et al.
Publicado: (2010)

Primary and Secondary/ Metastatic Salivary Duct Carcinoma Presenting within the Sinonasal Tract
por: Agaimy, Abbas, et al.
Publicado: (2021)

Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer
por: Du, Xinxing, et al.
Publicado: (2023)

Successful Treatment with Nivolumab in a Patient with Metastatic Salivary Duct Carcinoma
por: Sato, Tsuyoshi, et al.
Publicado: (2021)

Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer
por: Sasaki, Takeshi, et al.
Publicado: (2021)

Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis
por: Ge, Qingyu, et al.
Publicado: (2022)

Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease
por: Suzuki, Hiroyoshi, et al.
Publicado: (2021)

Integrative genomic analysis of salivary duct carcinoma
por: Kim, Youngwook, et al.
Publicado: (2020)

A Fatal Case of Primary Basaloid Squamous Cell Carcinoma in the Intrahepatic Bile Ducts
por: Kirkegaard, Johan, et al.
Publicado: (2014)

Salivary duct carcinoma of parotid gland
por: Kinnera, Vijay Sreedhar Babu, et al.
Publicado: (2009)

Salivary duct carcinoma of the parotid gland
por: Mlika, Mona, et al.
Publicado: (2012)

Salivary duct carcinoma of accessory parotid
por: Al-Hashim, Mohammed A., et al.
Publicado: (2017)

CT‐based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration‐naïve oligometastatic prostate cancer
por: Sheikhbahaei, Sara, et al.
Publicado: (2020)

Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer
por: Sugino, Fumiya, et al.
Publicado: (2023)

Androgen Deprivation Therapy for Patients with Androgen-Receptor-Positive Metastatic Salivary Duct Carcinoma: A Case Report and Review of the Literature
por: You, Yongfei, et al.
Publicado: (2021)

Expression of Mucins in Different Entities of Salivary Gland Cancer: Highest Expression of Mucin-1 in Salivary Duct Carcinoma: Mucin-1 – highest expression in Salivary Duct Carcinoma
por: Wolber, P., et al.
Publicado: (2022)

Locally advanced salivary duct carcinoma of the parotid gland
por: Kallianpur, Ashwin, et al.
Publicado: (2012)

Salivary duct carcinoma arising from the inferior turbinate
por: Vallabh, Nimisha, et al.
Publicado: (2017)

Cystic Salivary Duct Carcinoma Penetrated by Facial Nerve
por: Kim, Yunghoon, et al.
Publicado: (2022)

Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer
por: Matsuda, Yoshinori, et al.
Publicado: (2020)

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)

Adenoid Cystic Carcinoma of Sublingual Salivary Gland Obstructing the Submandibular Salivary Gland Duct
por: Kumar, Venkata Suneel, et al.
Publicado: (2013)

Acquisition of resistance to androgen deprivation therapy in salivary duct carcinoma: A case report
por: Wasano, Koichiro, et al.
Publicado: (2018)

Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients
por: van Boxtel, Wim, et al.
Publicado: (2019)

Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma
por: Kawakita, Daisuke, et al.
Publicado: (2022)

Androgen Deprivation Therapy for Intracranial Metastasis of a Salivary Duct Carcinoma: Case Report
por: Rösch, Manuel, et al.
Publicado: (2023)

Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma
por: Danno, Tetsuya, et al.
Publicado: (2021)

Affections of the salivary ducts in buffaloes
por: Misk, N.A., et al.
Publicado: (2014)

Salivary duct carcinoma with striking neutrophil-tumor cell cannibalism
por: Arya, Payam, et al.
Publicado: (2011)

Perineural Spread of Salivary Duct Carcinoma to the Internal Auditory Canal
por: Kitavi, Winfred, et al.
Publicado: (2014)

Somatic mutations in salivary duct carcinoma and potential therapeutic targets
por: Khoo, Timothy K., et al.
Publicado: (2017)

Cutaneous Metastases from Salivary Duct Carcinoma of the Submandibular Gland
por: Chakari, Wahida, et al.
Publicado: (2017)

Enhanced Angiogenesis in Salivary Duct Carcinoma Ex-Pleomorphic Adenoma
por: Suzuki, Takayoshi, et al.
Publicado: (2021)

Salivary Duct Carcinoma: Case Reports and Brief Review of the Literature
por: Kantamani, Deepti, et al.
Publicado: (2021)

Adjuvant Treatment of the Salivary Duct Carcinoma with Her2 Overexpression
por: Berendika, Jelena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s2enfcuccc2udea6emvatvm16c